Curcumin nanoparticles attenuate cardiac remodeling due to pulmonary arterial hypertension

Artificial Cells, Nanomedicine and Biotechnology

Volumn 44, Issue 8, 2016, Pages 1909-1916

  Rice, Kevin M ^a,b,c   Manne, Nandini D P K ^a   Kolli, Madhukar B ^a,c   Wehner, Paulette S ^c   Dornon, Lucy ^c   Arvapalli, Ravikumar ^a   Selvaraj, Vellaisamy ^a   Kumar, Arun ^d   Blough, Eric R ^a,b,c  

^a MARSHALL UNIVERSITY   (United States)

^b WEST VIRGINIA STATE UNIVERSITY   (United States)

^c MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF DELAWARE   (United States)

Author keywords

Cardiac hypertrophy; curcumin; nanoparticles; pulmonary arterial hypertension

Indexed keywords

ECHOCARDIOGRAPHY;

CARDIAC HYPERTROPHY; CARDIAC REMODELING; CURCUMIN; MRNA EXPRESSION; MYOSIN HEAVY CHAIN; PULMONARY ARTERIAL HYPERTENSION; RIGHT VENTRICLE; RIGHT VENTRICULAR;

NANOPARTICLES;

3 NITROTYROSINE; CURCUMIN; FIBRONECTIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; INTERLEUKIN 1BETA; MESSENGER RNA; MYOSIN HEAVY CHAIN BETA; NANOPARTICLE; TUMOR NECROSIS FACTOR; IL1B PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFICACY; GENE EXPRESSION; HEART RIGHT VENTRICLE; HEART VENTRICLE REMODELING; IMMUNOBLOTTING; M MODE ECHOCARDIOGRAPHY; MALE; MONOCROTALINE-INDUCED PULMONARY HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CHEMISTRY; COMPLICATION; DRUG EFFECTS; HEART VENTRICLE; HYPERTENSION, PULMONARY; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CURCUMIN; HEART VENTRICLES; HYPERTENSION, PULMONARY; INTERLEUKIN-1BETA; MALE; NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

EID: 84989944827     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2015.1111235     Document Type: Article

References (31)

1. R.Agarwal, M.Gomberg-Maitland. 2011. Current therapeutics and practical management strategies for pulmonary arterial hypertension. Am Heart J. 162:201.
2. B.B.Aggarwal, K.B.Harikumar. 2009. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 41:40.
3. P.Anand, C.Sundaram, S.Jhurani, A.B.Kunnumakkara, B.B.Aggarwal. 2008. Curcumin and cancer:an “old-age” disease with an ”age-old” solution. Cancer Lett. 267:133.
4. S.L.Archer, E.K.Weir, M.R.Wilkins. 2010. Basic science of pulmonary arterial hypertension for clinicians:new concepts and experimental therapies. Circulation. 121:2045.
5. A.N.Begum, M.R.Jones, G.P.Lim, T.Morihara, P.Kim, D.D.Heath, 2008. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther. 326:196.
6. H.J.Bogaard, K.Abe, A.Vonk Noordegraaf, N.F.Voelkel. 2009. The right ventricle under pressure:cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest. 135:794.
7. J.Boissiere, M.Gautier, M.C.Machet, G.Hanton, P.Bonnet, V.Eder. 2005. Doppler tissue imaging in assessment of pulmonary hypertension-induced right ventricle dysfunction. Am J Physiol Heart Circ Physiol. 289:H2450.
8. G.E.D'Alonzo, R.J.Barst, S.M.Ayres, E.H.Bergofsky, B.H.Brundage, K.M.Detre, 1991. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 115:343.
9. M.J.Faber, M.Dalinghaus, I.M.Lankhuizen, K.Bezstarosti, A.J.Verhoeven, D.J.Duncker, W.A.Helbing, J.M.Lamers. 2007. Time dependent changes in cytoplasmic proteins of the right ventricle during prolonged pressure overload. J Mol Cell Cardiol. 43:197.
10. J.Feng, Z.Gu, M.Wu, F.C.Gwazdauskas, H.Jiang. 2009. Growth hormone stimulation of serum insulin concentration in cattle:nutritional dependency and potential mechanisms. Domest Anim Endocrinol. 37:84.
11. Y.Fu, S.Zheng, J.Lin, J.Ryerse, A.Chen. 2008. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol. 73:399.
12. P.Garodia, H.Ichikawa, N.Malani, G.Sethi, B.B.Aggarwal. 2007. From ancient medicine to modern medicine:ayurvedic concepts of health and their role in inflammation and cancer. J Soc Integr Oncol. 5:25.
13. S.S.Ghosh, F.N.Salloum, A.Abbate, R.Krieg, D.A.Sica, T.W.Gehr, R.C.Kukreja. 2010. Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats. Am J Physiol Heart Circ Physiol. 299:H975.
14. J.G.Gomez-Arroyo, L.Farkas, A.A.Alhussaini, D.Farkas, D.Kraskauskas, N.F.Voelkel, H.J.Bogaard. 2012. The monocrotaline model of pulmonary hypertension in perspective. Am J Physiol Lung Cell Mol Physiol. 302:L363.
15. B.C.Henderson, U.Sen, C.Reynolds, K.S.Moshal, A.Ovechkin, N.Tyagi, 2007. Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone. Int J Biol Sci. 3:385.
16. M.Humbert, O.Sitbon, A.Chaouat, M.Bertocchi, G.Habib, V.Gressin, 2010. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 122:156.
17. M.B.Kolli, N.D.Manne, R.Para, S.K.Nalabotu, G.Nandyala, T.Shokuhfar, 2014. Cerium oxide nanoparticles attenuate monocrotaline induced right ventricular hypertrophy following pulmonary arterial hypertension. Biomaterials. 35:9951.
18. J.W.Koskenvuo, R.Mirsky, Y.Zhang, F.S.Angeli, S.Jahn, T.P.Alastalo, 2010. A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model. Int J Cardiovasc Imaging. 26:509.
19. N.D.Manne, M.Lima, R.T.Enos, P.Wehner, J.A.Carson, E.Blough. 2013. Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin/+ mouse. Int J Oncol. 42:2134.
20. T.Morimoto, Y.Sunagawa, T.Kawamura, T.Takaya, H.Wada, A.Nagasawa, 2008. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest. 118:868.
21. M.Okada, T.Harada, R.Kikuzuki, H.Yamawaki, Y.Hara. 2009. Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats. J Pharmacol Sci. 111:193.
22. N.Pathak, S.Khandelwal. 2008. Comparative efficacy of piperine, curcumin and picroliv against Cd immunotoxicity in mice. Biometals. 21:649.
23. D.Punithavathi, N.Venkatesan, M.Babu. 2000. Curcumin inhibition of bleomycin-induced pulmonary fibrosis in rats. Br J Pharmacol. 131:169.
24. A.E.Schultze, R.A.Roth. 1998. Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system. J Toxicol Environ Health B Crit Rev. 1:271.
25. K.Shahani, S.K.Swaminathan, D.Freeman, A.Blum, L.Ma, J.Panyam. 2010. Injectable sustained release microparticles of curcumin:a new concept for cancer chemoprevention. Cancer Res. 70:4443.
26. M.Takeuchi, T.Takahashi, N.Taga, T.Iwasaki, K.Ohe, H.Shimizu, 2003. Right ventricle of patients undergoing congenital cardiac surgery differentially expresses haem oxygenase-1 and heat shock protein 70 genes. J Int Med Res. 31:413.
27. S.Thulluri, M.Wu, E.R.Blough, N.D.Manne, A.B.Litchfield, B.Wang. 2012. Regulation of iron-related molecules in the rat hippocampus:sex- and age-associated differences. Ann Clin Lab Sci. 42:145.
28. S.Umar, P.Steendijk, D.L.Ypey, D.E.Atsma, E.E.van der Wall, M.J.Schalij, A.van der Laarse. 2010. Novel approaches to treat experimental pulmonary arterial hypertension:a review. J Biomed Biotechnol. 2010:702836.
29. D.W.Wilson, H.J.Segall, L.C.Pan, M.W.Lame, J.E.Estep, D.Morin. 1992. Mechanisms and pathology of monocrotaline pulmonary toxicity. Crit Rev Toxicol. 22:307.
30. M.Wu, J.B.Hall, R.M.Akers, H.Jiang. 2010. Effect of feeding level on serum IGF1 response to GH injection. J Endocrinol. 206:37.
31. Q.H.Yao, D.Q.Wang, C.C.Cui, Z.Y.Yuan, S.B.Chen, X.W.Yao, J.K.Wang, J.F.Lian. 2004. Curcumin ameliorates left ventricular function in rabbits with pressure overload:inhibition of the remodeling of the left ventricular collagen network associated with suppression of myocardial tumor necrosis factor-alpha and matrix metalloproteinase-2 expression. Biol Pharm Bull. 27:198.